New developments in prion disease research using genetically modified mouse models

被引:3
|
作者
Sun, Julianna L. L. [1 ]
Telling, Glenn C. C. [1 ]
机构
[1] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
基金
美国国家卫生研究院;
关键词
Prions; Strains; Chronic wasting disease; Transgenic mice; Gene-targeted mice; CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MICE EXPRESSING HUMAN; TRANSGENIC MICE; MULE DEER; VARIANT CJD; STRAIN VARIATION; SPECIES-BARRIER; TRANSMISSION;
D O I
10.1007/s00441-023-03761-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
While much of what we know about the general principles of protein-based information transfer derives from studies of experimentally adapted rodent prions, these laboratory strains are limited in their ability to recapitulate features of human and animal prions and the diseases they produce. Here, we review how recent approaches using genetically modified mice have informed our understanding of naturally occurring prion diseases, their strain properties, and the factors controlling their transmission and evolution. In light of the increasing importance of chronic wasting disease, the application of mouse transgenesis to study this burgeoning and highly contagious prion disorder, in particular recent insights derived from gene-targeting approaches, will be a major focus of this review.
引用
收藏
页码:33 / 46
页数:14
相关论文
共 50 条
  • [31] Genetically engineered mouse models of Parkinson's disease
    Crabtree, Donna M.
    Zhang, Jianhua
    BRAIN RESEARCH BULLETIN, 2012, 88 (01) : 13 - 32
  • [32] Genetically modified mice models for Alzheimer's disease
    Sankaranarayanan, Sethu
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (06) : 609 - 627
  • [33] Assessment of Cognitive Phenotyping in Inbred, Genetically Modified Mice, and Transgenic Mouse Models of Alzheimer's Disease
    Kim, Dong-Hee
    Jang, Yoon-Sun
    Jeon, Won Kyung
    Han, Jung-Soo
    EXPERIMENTAL NEUROBIOLOGY, 2019, 28 (02) : 146 - 157
  • [34] Genetically engineered mouse models in oncology research and cancer medicine
    Kersten, Kelly
    de Visser, Karin E.
    van Miltenburg, Martine H.
    Jonkers, Jos
    EMBO MOLECULAR MEDICINE, 2017, 9 (02) : 137 - 153
  • [35] Genetically Modified Mouse Models for Biomarker Discovery and Preclinical Drug Testing
    Kucherlapati, Raju
    CLINICAL CANCER RESEARCH, 2012, 18 (03) : 625 - 630
  • [36] Applications and limitations of genetically modified mouse models in drug discovery and development
    Lin, Jiunn H.
    CURRENT DRUG METABOLISM, 2008, 9 (05) : 419 - 438
  • [37] Genetically modified mouse models to help fight COVID-19
    Channabasavaiah B. Gurumurthy
    Rolen M. Quadros
    Guy P. Richardson
    Larisa Y. Poluektova
    Suzanne L. Mansour
    Masato Ohtsuka
    Nature Protocols, 2020, 15 : 3777 - 3787
  • [38] Genetically modified mouse models to study hepatic neutral lipid mobilization
    Haemmerle, Guenter
    Lass, Achim
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (05): : 879 - 894
  • [39] Genetically modified mouse models to help fight COVID-19
    Gurumurthy, Channabasavaiah B.
    Quadros, Rolen M.
    Richardson, Guy P.
    Poluektova, Larisa Y.
    Mansour, Suzanne L.
    Ohtsuka, Masato
    NATURE PROTOCOLS, 2020, 15 (12) : 3777 - 3787
  • [40] Regression of atherosclerosis: lessons learned from genetically modified mouse models
    Burke, Amy C.
    Huff, Murray W.
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (02) : 87 - 94